These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6334298)

  • 1. [Specific immunity of patients with newly detected tuberculosis during chemotherapy].
    Evdokimov VN
    Probl Tuberk; 1984 Sep; (9):33-8. PubMed ID: 6334298
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of patients with destructive pulmonary tuberculosis with indomethacin and tuberculostatic preparations].
    Litvin LM; Novosad MK
    Vrach Delo; 1990 May; (5):76-8. PubMed ID: 2396403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of antitubercular chemotherapy on immune status within the first 3 months of the start of short-term treatment].
    Cioflec D; Ion N; Tudorache V; Hudiţeanu O; Luţă V; Chira Z; Neagoe D; Stoienescu D; Jemna I; Sfetcu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(2):137-44. PubMed ID: 2849189
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunity parameters in children with prior intrathoracic tuberculosis].
    Elufimova VF; Mitinskaia LA; Iukhimenko NV; Romanova RIu; Abramova ZP; Dem'ianenko NV; Baenskiĭ AV
    Probl Tuberk; 2000; (2):23-5. PubMed ID: 10838903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological correction in progressive pulmonary tuberculosis].
    Maslennikov AA; Kamenev VF; Kolomiets VM
    Probl Tuberk Bolezn Legk; 2007; (9):30-3. PubMed ID: 18038603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological indices of patients with destructive pulmonary tuberculosis due to bovine and human Mycobacterium tuberculosis].
    Naubet'iarova AN; Syzdykova NS; Alenova AKh
    Probl Tuberk; 1987; (4):34-6. PubMed ID: 3110764
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological studies in the treatment of tuberculosis with flureniside].
    Sibirnaia RI
    Probl Tuberk; 1997; (5):27-8. PubMed ID: 9454246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of side effects of specific chemotherapy in patients with pulmonary tuberculosis].
    Batian AN; Abramovskaia AK; Batian ON
    Probl Tuberk; 1991; (7):60-2. PubMed ID: 1754594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chemotherapy on the immunological characteristics of patients with primary destructive pulmonary tuberculosis.
    Khomenko AG; Averbach MM; Litvinov VI; Gergert VJ; Chukanov VI
    Bull World Health Organ; 1984; 62(5):763-71. PubMed ID: 6391716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological status of newly detected patients with destructive pulmonary tuberculosis].
    Khomenko AG; Averbakh MM; Rudoĭ NM; Litvinov VI; Gergert VIa
    Probl Tuberk; 1979 Apr; (4):13-7. PubMed ID: 312495
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-immunological criteria of the effectiveness of chemotherapy in patients with destructive pulmonary tuberculosis].
    Ivaniuta OM; Kogosova LS; Il'nitskiĭ IG; Zamdborg IuL; Davyda RS
    Probl Tuberk; 1986; (2):42-5. PubMed ID: 3703842
    [No Abstract]   [Full Text] [Related]  

  • 12. [T- and b systems of immunity in patients with newly detected destructive pulmonary tuberculosis during complex therapy].
    Kogosova LS; Bal'tseva LV; Petrashenko AI
    Probl Tuberk; 1981 Feb; (2):24-8. PubMed ID: 6972527
    [No Abstract]   [Full Text] [Related]  

  • 13. [Problems of the optimal duration of chemotherapy in newly detected destructive pulmonary tuberculosis].
    Doroshenkova AE; Avtandilov GG
    Probl Tuberk; 1981 Jan; (1):58-61. PubMed ID: 7208468
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood T-lymphocyte functional activity in pulmonary tuberculosis patients undergoing chemotherapeutic agent and vitamin treatment].
    Volosevich GV
    Probl Tuberk; 1982 Mar; (3):47-50. PubMed ID: 6979747
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis].
    Ivanova LA
    Vrach Delo; 1989 Oct; (10):57-9. PubMed ID: 2617987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
    Karachunskiĭ MA; Gergert VIa; Iakovleva OB
    Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term results of chemotherapy of newly detected patients with destructive pulmonary tuberculosis].
    Roslik SM; Pashkov IuN; Matveeva SL; Iushchenko LP; Gerasimova TG; Liudvichek IA; Iakovleva LM; Stepanenko AL; Pankova LI
    Probl Tuberk; 1991; (2):33-6. PubMed ID: 2034639
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intermittent intravenous chemotherapy of patients with newly detected pulmonary tuberculosis].
    Serebrova NI; Kononenko VG; Sharapova LN; Kiskevich MI; Savelova SA
    Probl Tuberk; 1975; (3):51-4. PubMed ID: 1135203
    [No Abstract]   [Full Text] [Related]  

  • 19. [Laser and chemotherapy and the immune status of patients with fibrous-cavernous tuberculosis].
    Sergeeva LV; Dobkin VG; Markov AN
    Probl Tuberk; 1996; (1):22-4. PubMed ID: 8907479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of different chemotherapy regimens in newly detected patients with destructive pulmonary tuberculosis].
    Omarov TO; Shefer LB; V'iushkova SV; Abzharkenova ESh
    Probl Tuberk; 1987; (4):15-7. PubMed ID: 3601919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.